Name
#112 Transcranial Photobiomodulation Therapy as an Intervention for Opioid Cravings and Depression: A Pilot Cohort Study
Content Presented On Behalf Of:
Other entity not listed
Session Type
Poster
Date
Tuesday, March 3, 2026
Start Time
5:00 PM
End Time
7:00 PM
Location
Prince Georges Expo Hall E
Focus Areas/Topics
Clinical Care, Technology, Wellbeing, Trending/Hot Topics or Other not listed
Learning Outcomes
1. Describe the mechanisms by which 810 nm transcranial Photobiomodulation may influence craving and mood regulation.

2. Summarize the observed effects of whole-head tPBM on opioid craving and depressive symptoms in a residential rehabilitation setting.

3. Identify considerations for implementing brief tPBM protocols in wellness, rehabilitation, or military recovery programs.

4. Evaluate how non-pharmacologic adjunct interventions can support relapse prevention and emotional stabilization during recovery.
Session Currently Live
Description

Opioid use disorder (OUD) remains a pervasive public health challenge affecting civilian, Veteran, and active-duty military populations. Even when individuals achieve abstinence in structured treatment environments, cravings and depressive symptoms frequently persist and are among the strongest predictors of relapse. While pharmacotherapy and counseling remain central components of recovery, there is a growing need for accessible, non-pharmacologic, adjunctive interventions that can be delivered in diverse environments—including wellness centers, integrative care clinics, and residential rehabilitation programs. Photobiomodulation (PBM) is a non-invasive neuromodulation approach that uses near-infrared light to influence mitochondrial activity, cerebral blood flow, neural network signaling, and neuroinflammatory pathways associated with mood and reward-system regulation.